batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Seeking a better PRMT5 inhibitor 20 September 2023 Revolution in the next KRAS battleground 20 September 2023 The bad news just keeps coming for Kinnate 19 September 2023 Bayer looks to clinical validation for $1.5bn Vividion deal 18 September 2023 Europe sinks Blenrep 15 September 2023 World Lung 2023 – Impower-151 can’t repeat Impower-150’s lung cancer success 11 September 2023 World Lung 2023 – some support for TROP2 combos in first-line lung cancer 11 September 2023 Mariposa-2 might give J&J confidence in lazertinib 6 September 2023 Load More